RETMen2B-transgene produces sympathoadrenal tumors but does not prevent intestinal aganglionosis in gdnf-/- or gfrα-1-/- mice

Pediatric and Developmental Pathology

Volumn 4, Issue 5, 2001, Pages 446-453

  Rajan, Indrani ^a   Gestblom, Carolina ^a   Kapur, Raj P ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Animal model; Ganglioneuroma; Hirschsprung disease; Multiple endocrine neoplasia; RET receptor; Transgenic mice

Indexed keywords

GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR; GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR RECEPTOR ALPHA; GROWTH FACTOR RECEPTOR; METHIONINE; PROTEIN RET; THREONINE; TYROSINE KINASE RECEPTOR; UNCLASSIFIED DRUG;

AMINO ACID SUBSTITUTION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; GANGLIONEUROMA; GENE LOSS; GENE MUTATION; HIRSCHSPRUNG DISEASE; MOUSE; NERVE CELL; NEUROFIBROMATOSIS; NONHUMAN; PATHOGENESIS; PENETRANCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; STEM CELL; TRANSGENIC MOUSE;

ACETYLCHOLINESTERASE; ADRENAL GLAND NEOPLASMS; ANIMALS; ANIMALS, NEWBORN; CELIAC PLEXUS; COLON; DISEASE MODELS, ANIMAL; DNA; DROSOPHILA PROTEINS; FEMALE; GANGLIONEUROMA; GLIAL CELL LINE-DERIVED NEUROTROPHIC FACTOR RECEPTORS; HIRSCHSPRUNG DISEASE; IMAGE PROCESSING, COMPUTER-ASSISTED; MALE; MICE; MICE, KNOCKOUT; MICE, TRANSGENIC; MULTIPLE ENDOCRINE NEOPLASIA TYPE 2B; MYENTERIC PLEXUS; POLYMERASE CHAIN REACTION; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-RET; RECEPTOR PROTEIN-TYROSINE KINASES;

EID: 0034874269     PISSN: 10935266     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10024001-0039-9     Document Type: Article

References (35)

1. RET proto-oncogene in the development of human cancer
2. Mutations in Hirschsprung disease: When does a mutation contribute to the phenotype
3. Oncogenes and thyroid cancer
4. The GDNF family of ligands and receptors - Implications for neural development
5. GDNF: A glial cell line-derived neurotrophic factor for midbrain dopaminergic neurons
6. Neurturin, a relative of glial-cell-line-derived neurotrophic factor
7. Artemin, a novel member of the GDNF ligand family supports peripheral and central neurons and signals through the GFRα3-RET receptor
8. Persephin, a novel neurotrophic factor related to GDNF and neurturin
9. Binding of GDNF and neurturin to human GDNF family receptor α1 and 2 (GFRα1-2); influence of cRET and co-operative interactions
10. GFRalpha-mediated localization of RET to lipid rafts is required for effective downstream signaling
11. Identification of Shc docking site on Ret tyrosine kinase
12. Renal agenesis and the absence of enteric neurons in mice lacking GDNF
13. Defects in enteric innervation and kidney development in mice lacking GDNF
14. Renal and neuronal abnormalities in mice lacking GDNF
15. GFRα1 is an essential receptor component for GDNF in the developing nervous system and kidney
16. GFRα1-deficient mice have deficits in the enteric nervous system and kidneys
17. Defects in the kidney and enteric nervous system of mice lacking the tyrosine kinase receptor Ret
18. Single missense mutation in the tyrosine kinase catalytic domain of the RET protooncogene is associated with multiple endocrine neoplasia type 2B, genesis
19. Catalytic specificity of protein-tyrosine kinases is critical for selective signalling
20. RET activation by germline MEN2A and MEN2B mutations
21. Ligand stimulation of a Ret chimeric receptor carrying the activating mutation responsible for the multiple endocrine neoplasia type 2B
22. Glial cell line-derived neurotrophic factor differentially stimulates ret mutants associated with the multiple endocrine neoplasia type 2 syndromes and Hirschsprung's disease
23. Full activation of MEN2B mutant RET by an additional MEN2A mutation or by ligand GDNF stimulation
24. Ganglioneuromas and renal anomalies are induced by activated RetMEN2B in transgenic mice
25. C-cell hyperplasia, pheochromocytoma and sympathoadrenal malformation in a mouse model of multiple endocrine neoplasia type 2B
26. Fine structure mapping and deletion analysis of the murine piebald locus
27. An acetylcholinesterase method for in toto staining of peripheral nerves
28. Transgenic rescue of aganglionosis and piebaldism in lethal spotted mice
29. A transgenic model for studying development of the enteric nervous system in normal and aganglionic mice
30. Activation of RET as a: Dominant transforming gene by germline mutations of MEN2A and MEN2B
31. Expression of RET and its ligand complexes, GDNF/GFRalpha-1 and NTN/GFRalpha-2, in medullary thyroid carcinomas
32. Signalling by the RET receptor tyrosine kinase and its role in the development of the mammalian enteric nervous system
33. The RET protooncogene induces apoptosis: A novel mechanism for Hirschsprung disease
34. Dominant effects of RET receptor misexpression and ligand-independent RET signaling on ureteric bud development
35. MEN2B-transgenic mice